Parathyroid hormone is a single chain polypeptide made up of 84 amino acids secreted by the parathyroid gland located near the thyroid gland. Inadequate secretion of parathyroid hormone results in the development of diseases related to bone such as osteoporosis, hypocalcaemia, and hyperphosphetemia. Parathyroid hormone controls the distribution of phosphate and calcium in the body. Hypoparathyroidism is a condition, wherein parathyroid glands do not produce sufficient amount of parathyroid hormone (PTH). The disease is characterized by low level of calcium and high levels of phosphate in the blood. According to statistics by Verdict Media Limited., approximately 100,000 people in the U.S. are diagnosed with hyperparathyroidism.
Increase in incidence and prevalence of conditions related to the imbalance in the parathyroid hormone level in the body due to changing lifestyles, surge in R&D on the development of parathyroid hormone analogues, and improved diagnostic procedures for the detection of parathyroid hormone imbalance are projected to drive the global parathyroid hormone market during the forecast period. In April 2017, Shire plc received approval from the European Commission for Natpar (rhPTH[1-84]). It is the first recombinant human protein with the full length 84-amino acid sequence of endogenous parathyroid hormone (PTH). Moreover, hypoparathyroidism is a rare disease. Hence, the products developed for its treatment are getting orphan drugs designation, leading to increase in research and development in this therapy area. However, complicated process of product development, high cost of manufacturing, and increasingly stringent regulatory requirements are anticipated to restrain the market during the forecast period.
The global parathyroid hormone market can be segmented based on product type, indication, end-user, and region. In terms of product type, the parathyroid hormone market can be bifurcated into recombinant parathyroid hormones and parathyroid hormone analogues. The parathyroid hormone analogues segment includes teriparatide and abaloparatide. Based on indication, the global parathyroid hormone market can be classified into hypoparathyroidism, osteoporosis, and postmenopausal bone complications. In terms of end-user, the parathyroid hormone market can be divided into hospitals, clinics, and others. The hospitals segment is anticipated to account for major parathyroid hormone market share during the forecast period. However, the clinics segment is likely to expand at the highest CAGR from 2018 to 2026 owing to rise in patient preference for clinics due to improved medical services, cleanliness, and favorable reimbursement scenario.
Based on region, the global parathyroid hormone market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global parathyroid hormone market owing to high incidence rate of hypoparathyroidism, increase in health care spending, rise in investment in research related to parathyroid hormone product development by players, and surge in new product approvals in the region. Europe is anticipated to be the second largest market for parathyroid hormone in terms of revenue during the forecast period. Presence of large geriatric population is expected to propel the market in the region. The parathyroid hormone market in Asia Pacific is likely to expand at the highest CAGR due to economy growth and rise in health care expenditure in the developing countries.
Key players operating in the global parathyroid hormone market include Shire plc, Eli Lilly and Company, Physicians Total Care, Inc., and Radius Health, Inc. Large number of players are participating in the clinical trials of the parathyroid hormone products including Pfizer, Inc. Ascendis Pharma A/S, Entera Bio Ltd., and Extend Biosciences, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.